Winimed Oil 50 Deus Medical

£88.00

Winimed Oil 50 Deus Medical represents injectable stanozolol formulation in oil carrier for advanced laboratory investigations into androgenic steroid mechanisms and tissue-selective effects in controlled research environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Winimed Oil 50 Deus Medical
Winimed Oil 50 Deus Medical
£88.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Laboratory-Grade Stanozolol Oil Injectable

Winimed Oil 50 Deus Medical is a synthetic anabolic-androgenic steroid formulated as an injectable oil suspension for sophisticated laboratory research applications. This stanozolol preparation offers researchers at Stroid UK Shop a platform to investigate the molecular mechanisms of dihydrotestosterone-derived compounds and their tissue-specific androgenic activity profiles in controlled experimental settings.

The oil-based formulation provides enhanced stability and controlled release characteristics compared to aqueous suspensions, making it particularly valuable for extended research protocols examining steroid pharmacokinetics and bioavailability. Research teams investigating anabolic steroid mechanisms will find this preparation useful for studies examining protein synthesis pathways, nitrogen retention mechanisms, and the differential tissue effects that distinguish stanozolol from other androgenic compounds.

Advanced Research Applications

Laboratory studies utilising this stanozolol formulation focus on examining the compound’s unique structural modifications that confer reduced androgenic activity relative to testosterone while maintaining anabolic properties. Researchers studying comparative steroid biochemistry often investigate stanozolol’s interaction with androgen receptors and its effects on sex hormone-binding globulin levels in experimental models. The oil carrier system enables precise dosimetric studies and extended observation periods.

Comparative research with other compounds available through our stanozolol research category allows for comprehensive analysis of structural-activity relationships within the dihydrotestosterone family. Studies examining hepatic metabolism pathways and 17α-alkylation effects benefit from this injectable formulation’s bypassing of first-pass metabolism, providing distinct pharmacokinetic profiles for comparative analysis.

Technical Specifications

Winimed Oil 50 Laboratory Specifications
Parameter Specification
Active Compound Stanozolol
Concentration 50mg/mL
Formulation Oil-based injection
Manufacturer Deus Medical
Storage Requirements Room temperature, protected from light
Molecular Formula C₂₁H₃₂N₂O
CAS Registry 10418-03-8
Molecular Weight 328.49 g/mol

Research institutions studying steroid structure-activity relationships often compare stanozolol with selective androgen receptor modulators to understand tissue selectivity mechanisms. Advanced studies may incorporate research peptides to examine growth factor interactions and anabolic pathway synergies in experimental models.

Research Compliance

Winimed Oil 50 Deus Medical is manufactured exclusively for in-vitro laboratory research applications. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure compliance with institutional guidelines and applicable regulations governing androgenic steroid research. All investigations should be conducted under appropriate laboratory safety protocols with proper documentation and oversight.

Related